Literature DB >> 2974057

Functional and biochemical characterization of rat bone marrow derived mast cells.

D H Broide1, D D Metcalfe, S I Wasserman.   

Abstract

The functional and biochemical characterization of rat bone marrow derived mast cells (RBMMC) confirms both species-related differences between rat and mouse bone marrow-derived mast cells (MBMMC) as well as mast cell heterogeneity in a single species. Such RBMMC have the staining characteristics of mucosal mast cells and contain the mucosal mast cell protease. The RBMMC release the preformed granule mediator beta-hexosaminidase both in response to immunologic stimulation with 200 ng Ag (net release 15.8 +/- 3.8%) and in response to 1 microM calcium ionophore A23187 (net release 21.8 +/- 6.8%). However, compound 48/80, substance P, and somatostatin did not induce mast cell degranulation. In experiments with optimal beta-hexosaminidase release, the RBMMC generated similar quantities of the newly formed arachidonic acid metabolites leukotriene C4 and PGD2 when stimulated with either Ag or calcium ionophore A23187. The RBMMC incorporate [35S]sulfate into proteoglycans consisting of 90% chondroitin sulfates and 10% heparin. The chondroitin sulfates were comprised of chondroitin 4 sulfate and chondroitin sulfate diB sulfated disaccharides in a ratio of 4/1. Although we show that RBMMC and MBMMC share a low histamine content, functional IgE receptors and unresponsiveness to cromolyn and selective secretagogues (compound 48/80, substance P, and somatostatin), we also provide evidence that RBMMC differ from MBMMC in their profile of newly generated mediators, preformed granule proteoglycan, and lack of proliferative response to mouse IL-3.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974057

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay.

Authors:  P B Hill; A J MacDonald; E M Thornton; G F Newlands; S J Galli; H R Miller
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 2.  Mast cell proteoglycans.

Authors:  Elin Rönnberg; Fabio R Melo; Gunnar Pejler
Journal:  J Histochem Cytochem       Date:  2012-08-16       Impact factor: 2.479

3.  Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice.

Authors:  Tatsuya Oka; Janet Kalesnikoff; Philipp Starkl; Mindy Tsai; Stephen J Galli
Journal:  Lab Invest       Date:  2012-08-20       Impact factor: 5.662

4.  Rat mucosal mast cells: the cultured bone marrow-derived mast cell is biochemically and functionally analogous to its counterpart in vivo.

Authors:  A J MacDonald; J Pick; E Y Bissonnette; A D Befus
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

5.  The role of activated adenosine receptors in degranulation of human LAD2 mast cells.

Authors:  Chi Ting Leung; Ang Li; Juni Banerjee; Zhan-Guo Gao; Taku Kambayashi; Kenneth A Jacobson; Mortimer M Civan
Journal:  Purinergic Signal       Date:  2014-03-05       Impact factor: 3.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.